Breast Cancer Awareness 2025: Access and Awareness Saves Lives

Oct 16, 2025 | Non classé

Breast cancer remains the most common cancer among women worldwide. In the United States, statistics suggest that one in eight women will receive a diagnosis in her lifetime. In 2025 alone, it is estimated that 316,950 women and 2,800 men will be diagnosed with invasive breast cancer, with an additional 59,080 new cases of non-invasive breast cancer.

While these figures are sobering, there is progress. Early detection significantly improves outcomes. In the US, women diagnosed with localised breast cancer have a five-year survival rate at 99%. Today, over four million breast cancer survivors serve as a testament to the life-saving impact of awareness, early diagnosis and effective access to treatment.

However, the situation in many parts of the world is far more challenging

The African continent is experiencing a breast cancer crisis, with the highest mortality rates globally. Between 60 and 70% of women in African countries are diagnosed at advanced stages, when treatment is more difficult and less effective. In sub-Saharan Africa, half of women diagnosed with breast cancer survive for five years. In high-income countries, that figure exceeds 90%.

The reasons are clear. Early detection is hindered by low awareness and limited access to diagnostic and treatment services. Across many African nations, a single oncologist may care for between 500 and 1,000 patients (up to four times the recommended ratio). For many women, the barriers are not only medical but social. Fear, stigma and financial hardship often delay or prevent them from seeking help.

In this time of challenge, African women are stepping forward to lead change

Launched during Breast Cancer Awareness Month in 2024, the Africa Breast Cancer Council brings together a group of influential leaders – healthcare professionals, oncologists, former ministers, economists and First Ladies – united by a single goal: to change the future of breast cancer care in Africa.

The Council works to drive systemic reform. It aims to make breast cancer a national health priority, strengthen collaboration across governments and institutions, and advocate for scalable, sustainable solutions that improve survival rates for women across the continent.

Dr Magda Robalo, Council member and President of the Institute for Global Health and Development, said:

“Most African women with breast cancer are diagnosed too late and, even after a diagnosis, many do not receive the treatment they need. This egregious injustice is utterly preventable.”

Breast cancer is a global issue, but outcomes should not depend on where a woman lives. This Breast Cancer Awareness Month, the message is simple: awareness saves lives, but access and equity keep them alive.

https://www.nationalbreastcancer.org/breast-cancer-facts/

https://africabreastcancercouncil.org/

https://africa.roche.com/stories/africa-breast-cancer-council

Digital twins in clinical trials: opportunities and challenges

Digital twins in clinical trials: opportunities and challenges

A Digital Twin (DT) is a virtual representation of a physical entity, such as a patient or system, designed to simulate real world processes with precision. It enables the generation of a complete and realistic clinical patient trajectory, including modelling patient...

The second Pharmalys Voice meeting, June 2026

The second Pharmalys Voice meeting, June 2026

On 25 June 2026, Pharmalys colleagues came together virtually for the second Pharmalys Voice meeting of the year.  The meeting welcomed 35 participants across four continents, providing an opportunity to connect, exchange knowledge and celebrate the expertise...

Pharmalys at TCIS Africa Conference 2026, Pretoria, South Africa

Pharmalys at TCIS Africa Conference 2026, Pretoria, South Africa

Pharmalys assigned Jeanette, GCLP Team Lead, as the official Pharmalys representative the TCIS Africa Conference, held in Pretoria, South Africa, on 4–5 May 2026. The conference brought together a diverse and highly engaged community of professionals working across...

Pharmalys completes another successful GCLP audit in Romania

Pharmalys completes another successful GCLP audit in Romania

Pharmalys is pleased to announce the successful completion of another Good Clinical Laboratory Practice (GCLP) audit, conducted on 4-5 June 2026 at Medicover Integrated Clinical Services and its affiliated laboratory diagnostic services provider, Synevo Romania. The...